These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18268061)

  • 1. Differential relationships between basal and post-load insulin resistance indices and hepatic fibrosis in chronic hepatitis C and in non-alcoholic fatty liver disease.
    Targher G; Zoppini G; Muggeo M
    Gut; 2008 Mar; 57(3):426; author reply 426-7. PubMed ID: 18268061
    [No Abstract]   [Full Text] [Related]  

  • 2. Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease.
    Svegliati-Baroni G; Bugianesi E; Bouserhal T; Marini F; Ridolfi F; Tarsetti F; Ancarani F; Petrelli E; Peruzzi E; Lo Cascio M; Rizzetto M; Marchesini G; Benedetti A
    Gut; 2007 Sep; 56(9):1296-301. PubMed ID: 17392334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV/hepatitis C co-infection and hepatic fibrosis: looking beyond HIV-associated immune suppression; the contribution of hepatic steatosis and insulin resistance.
    Bhagani S
    Gut; 2009 Dec; 58(12):1579-81. PubMed ID: 19923343
    [No Abstract]   [Full Text] [Related]  

  • 4. Review article: the pathogenesis of fibrosis in non-alcoholic steatohepatitis.
    Marra F; Aleffi S; Bertolani C; Petrai I; Vizzutti F
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():44-7. PubMed ID: 16225472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic factors and non-alcoholic fatty liver disease as co-factors in other liver diseases.
    Powell EE; Jonsson JR; Clouston AD
    Dig Dis; 2010; 28(1):186-91. PubMed ID: 20460909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C.
    Younossi ZM; Afendy A; Stepanova M; Hossain N; Younossi I; Ankrah K; Gramlich T; Baranova A
    Liver Int; 2009 Oct; 29(9):1403-12. PubMed ID: 19515216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus and nonalcoholic Fatty liver disease: similar risk factors for necroinflammation, fibrosis, and cirrhosis.
    Comparcola D; Alisi A; Nobili V
    Clin Gastroenterol Hepatol; 2010 Jan; 8(1):97; author reply 97. PubMed ID: 19772950
    [No Abstract]   [Full Text] [Related]  

  • 8. Glucose abnormalities in non-alcoholic fatty liver disease and chronic hepatitis C virus infection: the role of iron overload.
    Lecube A; Hernández C; Simó R
    Diabetes Metab Res Rev; 2009 Jul; 25(5):403-10. PubMed ID: 19444865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease-specific mechanisms of fibrosis: hepatitis C virus and nonalcoholic steatohepatitis.
    van der Poorten D; George J
    Clin Liver Dis; 2008 Nov; 12(4):805-24, ix. PubMed ID: 18984468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-alcoholic fatty liver disease].
    Calderaro J; Zafrani ES
    Ann Pathol; 2010 Dec; 30(6):413-20. PubMed ID: 21167426
    [No Abstract]   [Full Text] [Related]  

  • 11. [A review on the relationship between metabolic syndrome and chronic hepatitis B].
    Chan HL; Shi JP
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):807-8. PubMed ID: 19958636
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of obesity, steatosis and insulin resistance on progression and response to therapy of hepatitis C.
    Negro F; Clément S
    J Viral Hepat; 2009 Oct; 16(10):681-8. PubMed ID: 19732324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance and metabolic syndrome in chronic liver diseases: old entities with new implications.
    Tsochatzis EA; Manolakopoulos S; Papatheodoridis GV; Archimandritis AJ
    Scand J Gastroenterol; 2009; 44(1):6-14. PubMed ID: 18661429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C.
    Rafiq N; Younossi ZM
    Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):207-15. PubMed ID: 19072356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The presence of steatosis and elevation of alanine aminotransferase levels are associated with fibrosis progression in chronic hepatitis C with non-response to interferon therapy.
    Kurosaki M; Matsunaga K; Hirayama I; Tanaka T; Sato M; Komatsu N; Umeda N; Hosokawa T; Ueda K; Tsuchiya K; Nakanishi H; Itakura J; Asahina Y; Miyake S; Enomoto N; Izumi N
    J Hepatol; 2008 May; 48(5):736-42. PubMed ID: 18329125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic steatosis and fibrosis in young men with treatment-naïve chronic hepatitis B.
    Yun JW; Cho YK; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Son BH; Shin JH
    Liver Int; 2009 Jul; 29(6):878-83. PubMed ID: 19192167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NASH and HCC.
    Page JM; Harrison SA
    Clin Liver Dis; 2009 Nov; 13(4):631-47. PubMed ID: 19818310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of host insulin resistance on fibrosis and response to interferon in chronic hepatitis C.
    Moţa M; Popa S; Mota E; Diaconescu I; Gheorghiţoiu I; Panduru M
    Rom J Intern Med; 2008; 46(2):105-12. PubMed ID: 19284081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking is associated with steatosis and severe fibrosis in chronic hepatitis C but not B.
    Tsochatzis E; Papatheodoridis GV; Manolakopoulos S; Tiniakos DG; Manesis EK; Archimandritis AJ
    Scand J Gastroenterol; 2009; 44(6):752-9. PubMed ID: 19296398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes in chronic liver disease: from old concepts to new evidence.
    Picardi A; D'Avola D; Gentilucci UV; Galati G; Fiori E; Spataro S; Afeltra A
    Diabetes Metab Res Rev; 2006; 22(4):274-83. PubMed ID: 16506276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.